World's Best Scientists 2026 revealed!
Jack A. Schalken

Jack A. Schalken

D-Index & Metrics

Medicine

D-Index
96
Citations
34900
World Ranking
9635
National Ranking
372

Jack A. Schalken publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jack A. Schalken sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 612 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jack A. Schalken D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jack A. Schalken sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jack A. Schalken is affiliated with Radboud University in the Netherlands. Their research focuses primarily on medicine, with substantial contributions in biochemistry, genetics, and molecular biology. The scientist's subfields of study include pulmonary and respiratory medicine, cancer research, oncology, molecular biology, and surgery.

Schalken's recent publications cover a range of topics related to cancer and molecular diagnostics. Notable papers include:

  • Detection and localization of early- and late-stage cancers using platelet RNA (2022, Cancer Cell)
  • Liquid biopsy in bladder cancer: State of the art and future perspectives (2022, Critical Reviews in Oncology/Hematology)
  • Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men (2021, Prostate Cancer and Prostatic Diseases)
  • 68Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study (2020, Theranostics)
  • Prostate Cancer Liquid Biopsy Biomarkers' Clinical Utility in Diagnosis and Prognosis (2021, Cancers)

Their research covers various main topics, including:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Salivary Gland Tumors Diagnosis and Treatment
  • Cancer-related molecular mechanisms research
  • Bladder and Urothelial Cancer Treatments
  • Cancer, Lipids, and Metabolism

Schalken often publishes in certain venues repeatedly. Frequent publication venues include:

  • The Prostate
  • Cancers
  • European Urology Open Science
  • Nature Reviews Urology
  • Oral Oncology

Collaboration is a significant part of their work, with frequent co-authors such as:

  • Niven Mehra
  • Gerald W. Verhaegh
  • Inge M. van Oort
  • Tapio Visakorpi
  • Onno van Hooij

Jack A. Schalken's scientific output reflects a deep engagement with clinical and molecular aspects of cancer, with a specific focus on prostate cancer, bladder cancer, and salivary gland tumors. Their work spans fundamental research in molecular biology to applied clinical diagnostics and imaging techniques.

Best Publications

  • DD3::A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer

    M.J.G. Bussemakers;A. van Bokhoven;G.W.C.T. Verhaegh;F.P. Smit

  • DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

    Daphne Hessels;Jacqueline M.T. Klein Gunnewiek;Inge van Oort;Herbert F.M. Karthaus

  • DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.

    Jacques B de Kok;Gerald W Verhaegh;Rian W Roelofs;Daphne Hessels

  • Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

    Umbas R;Schalken Ja;Aalders Tw;Carter Bs

  • Decreased E-Cadherin Expression Is Associated with Poor Prognosis in Patients with Prostate Cancer

    R. Umbas;W. B. Isaacs;P. P. Bringuier;H. E. Schaafsma

  • Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.

    Thorunn Rafnar;Patrick Sulem;Simon N Stacey;Frank Geller

  • Allelic loss of chromosomes 16q and 10q in human prostate cancer.

    B S Carter;C M Ewing;W S Ward;B F Treiger

  • Cadherin Switching in Human Prostate Cancer Progression

    K. Tomita;A. Van Bokhoven;G. J. L. H. Van Leenders;E. T. G. Ruijter

  • Prevention and early detection of prostate cancer

    Jack Cuzick;Mangesh A Thorat;Gerald L Andriole;Otis W Brawley;Otis W Brawley

  • Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

    Alexander Haese;Alexandre de la Taille;Hendrik van Poppel;Michael Marberger

  • Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

    Vinata B. Lokeshwar;Tomonori Habuchi;H. Barton Grossman;William M. Murphy

  • Decreased E-Cadherin Immunoreactivity Correlates with Poor Survival in Patients with Bladder Tumors

    P. P. Bringuier;R. Umbas;H. E. Schaafsma;H. F. M. Karthaus

  • ETS gene fusions in prostate cancer: from discovery to daily clinical practice.

    Scott A. Tomlins;Anders Bjartell;Arul M. Chinnaiyan;Guido Jenster

  • Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate Cancer

    D. Hessels;F.P. Smit;G.W.C.T. Verhaegh;J.A. Witjes

  • Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer ☆

    Gisele H.J.M. Leyten;Daphne Hessels;Sander A. Jannink;Frank P. Smit

  • Androgen receptors in endocrine-therapy-resistant human prostate cancer

    T. H. Van Der Kwast;J. Schalken;J. A. Ruizeveld De Winter;C. C. J. Van Vroonhoven

  • Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score

    Leander Van Neste;Rianne J Hendriks;Siebren Dijkstra;Geert Trooskens

  • Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss

    J T Dong;H Suzuki;S S Pin;G S Bova

  • Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

    S Gillessen;A Omlin;G Attard;J S de Bono

  • Cadherin Switching in Human Prostate Cancer Progression

    Jack A Schalken

Frequent Co-Authors

Peter F.A. Mulders
Peter F.A. Mulders Radboud University
Lambertus A. Kiemeney
Lambertus A. Kiemeney Radboud University
J. Alfred Witjes
J. Alfred Witjes Radboud University
Wim Van Criekinge
Wim Van Criekinge Ghent University
Alexandre de la Taille
Alexandre de la Taille Université Paris Cité
Michael Marberger
Michael Marberger Medical University of Vienna
Hartwig Huland
Hartwig Huland Universität Hamburg
Arnulf Stenzl
Arnulf Stenzl University of Tübingen
Winald R. Gerritsen
Winald R. Gerritsen Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t always require a traditional route. There are several online degree options and healthcare pathways you can explore from home. For practicing nurses seeking career advancement, finding the cheapest online dnp programs can be a cost-effective way to earn a terminal nursing degree and open doors to leadership or advanced clinical roles.

Pharmacy is another growing field. Today, the best online pharmacy school options offer flexibility for working professionals or those managing other responsibilities, making it easier to qualify as a licensed pharmacist.

Not every medical role is clinical. With the healthcare industry’s increasing use of digital records, a degree in health informatics can lead to in-demand jobs managing patient data and improving care quality through technology.

If you prefer working with healthcare data, exploring training and certification in medical billing and coding could be ideal. Wondering how much is medical billing and coding school? Online programs make this path more accessible and budget-friendly while preparing you for key administrative roles in clinics and hospitals.

Best Scientists Citing Jack A. Schalken

Trending Scientists